Int. Journal of Clinical Pharmacology and Therapeutics, Volume 63 (2025) - August (372 - 376)

Augmented renal clearance in neurosurgical patients receiving vancomycin: Limited prognostic value for the duration of hospitalization, treatment course, fever, and changes in the CSF test and CRP

Lu Sun, Yunchuan Sun
Department of Pharmacy, Beijing Tongren Hospital, Capital Medical University, Beijing, China

Add to Cart    

 

DOI 10.5414/CP204743

Abstract

Objective: In patients with augmented renal clearance (ARC) receiving vancomycin, therapeutic drug monitoring (TDM) is recommended in accordance with the 2020 guidelines. This study was conducted to delineate the profile of ARC and TDM in non-critically ill, non-trauma, non-stroke neurosurgical patients receiving vancomycin, thereby elucidating the additional risk factors and prognostic implications of ARC.
Materials and methods: A single-center retrospective review of clinical data was performed from patients who were consecutively admitted to the Neurosurgical Department of Beijing Tongren Hospital, Capital Medical University, Beijing, China, from November 1, 2017, to October 31, 2022, and received vancomycin. 62 patients with a maximum ICU stay of 72 hours were included. ARC was defined as an estimated glomerular filtration rate (eGFR) of > 130 mL/min/1.73m2 in the main analysis. A difference analysis based on ARC risk factors, correlation analysis, and multiple linear regression was conducted.
Results: The eGFR of the total patient cohort was 115.41 ± 13.39 mL/min/1.73m2 (mean ± SD), whereas 10 patients (16.13%) had eGFRs > 130 mL/min/1.73m2. Younger ages and mannitol co-administration were risk factors for ARC, whereas increased eGFR was not associated with prognostic implications for hospital stay, treatment course, fever duration, or duration to normalization of the CSF test or CRP level.
Conclusion: A minimum of 16.13% of non-critical, non-trauma, non-stroke neurosurgical patients exhibit ARC. ARC was not associated with anti-infection prognosis. This finding suggests that further evaluation of ARC-guided TDM of these populations is warranted.

Author Details

Authors

Departments

  • Department of Pharmacy, Beijing Tongren Hospital, Capital Medical University, Beijing, China

Address

Yunchuan Sun, M. Pharm.
Department of Pharmacy, Beijing Tongren Hospital
Capital Medical University
No.2, Xihuan South Road, Beijing Etown
Beijing 100176, China
Email: [email protected]

Citation

Lu Sun, Yunchuan Sun.Augmented renal clearance in neurosurgical patients receiving vancomycin: Limited prognostic value for the duration of hospitalization, treatment course, fever, and changes in the CSF test and CRP
. Int J Clin Pharmacol Ther. 2025; 63: 372-376. doi: 10.5414/CP204743. Pubmed: https://pubmed.ncbi.nlm.nih.gov/40302521/; PMID: 40302521.

###article_not_exists_msg###

Shopping Overview

Shopping Overview
Type Qtty Discount VAT Price
Your basket is empty
View Cart